Significance of S100A4 as a prognostic marker of lung squamous cell carcinoma

Anticancer Research

Volumn 29, Issue 7, 2009, Pages 2547-2554

  Tsuna, Mika ^a,d   Kageyama, Shun Ichiro ^b   Fukuoka, Junya ^b   Kitano, Haruhisa ^b   Doki, Yoshinori ^c   Tezuka, Hideo ^d   Yasuda, Hideyo ^a,e  

^a Kanagawa 243 0041   (Japan)

^b TOYAMA UNIVERSITY HOSPITAL   (Japan)

^c UNIVERSITY OF TOYAMA   (Japan)

^d UNIVERSITY OF YAMANASHI   (Japan)

^e UNIVERSITY OF TEXAS   (United States)

Author keywords

Immunohistochemistry; Lung cancer; Prognosis; S100A4; Tissue microarray

Indexed keywords

CALVASCULIN; MONOCLONAL ANTIBODY;

ADULT; ANTIBODY SPECIFICITY; ARTICLE; CANCER SURVIVAL; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TISSUE MICROARRAY; VALIDATION STUDY;

BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; DNA PRIMERS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; S100 PROTEINS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 69249167991     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Parkin DM, Pisani P and Ferlay J: Global cancer statistics. CA-Cancer J Clin 49: 33-64, 1999.
2. Sherbet GV and Lakshmi MS: S100A4 (MTS1) calcium-binding protein in cancer growth, invasion and metastasis. Anticancer Res 18: 2415-2421, 1998.
3. Helfman DM, Kim EJ, Lukanidin E and Grigorian M: The metastasis associated protein S100A4: role in tumour progression and metastasis. Br J Cancer 92: 1955-1958, 2005.
4. Sastry M, Ketchem RR, Crescenzi O, Weber C, Lubienski MJ, Hidaka H and Chazin WJ: The three-dimensional structure of Ca(2+)-bound calcyclin: implications for Ca(2+)-signal transduction by S100 proteins. Structure 6: 223-231, 1998.
5. Watanabe Y, Usada HN Minami H, Morita T, Tsugane S, Ishikawa R, Kohama K, Tomida Y and Hidaka H: Calvasculin, as a factor affecting the microfilament assmblies in rat fibroblasts transfected by src gene. FEBS Lett 324: 51-55, 1993. (Pubitemid 23165035)
6. Kriajevska MV, Cardenas MN, Griorian MS, Ambartsumian NS, Georgiev GP and Lukanidin EM: Non-muscle myosin heavy chain as a possible target for protein encoded by metastasis-related mts-1 gene. J Biol Chem 269: 19679-19682, 1994.
7. Fernandez-Fernandez MR, Veprinntsev DB and Fersht AR: Proteins of the S100 family regulate the oligomerization of p53 tumor suppressor. Proc Natl Acad Sci USA 102: 4735-4740, 2005. (Pubitemid 40471523)
8. Fernandez-Fernandez MR, Rutherford TJ and Fersht AR: Members of the S100 family bind p53 in two distinct ways. Protein Sci 17: 1663-1670, 2008.
9. Grigorian M, Andresen S, Tulchinsky E, Kriajevska M, Carlberg C, Kruse C, Cohn M, Ambartsumian N, Christensen A, Selivanova G and Lukanidin E: Tumor suppressor p53 protein is a new target for the metastasis-associated Mts1/S100A4 protein: functional consequences of their interaction. J Biol Chem 276: 22699-22708, 2001. (Pubitemid 33647703)
10. Rudland PS, Platt-Higgins A, Renshaw C, West CR, Winstanley JHR, Robertson L and Barraclough R: Prognostic significance of the metastasis-inducing protein S100A4 (p9Ka) in human breast cancer. Cancer Res 60: 1595-1603, 2000. (Pubitemid 30183430)
11. Hemandas AK, Saito-Tellez M, Maricar SH, Leong AF and Leow CK: Metastasis-associated protein S100A4 - a potential prognostic marker for colorectal cancer. J Surg Oncol 93: 498-503, 2006.
12. Matsumoto K, Irie A, Satoh T, Ishii J, Iwabuchi K, Iwamura M, Egawa S and Baba S: Expression of S100A2 and S100A4 predicts for disease progression and patient survival in bladder cancer. Urology 70: 602-607, 2007. (Pubitemid 47464477)
13. Ai KX, Lu LY, Huang XY, Chen W and Zhang HZ: Prognostic significance of S100A4 and vascular endothelial growth factor expression in pancreatic cancer. World J Gastroenterol 14: 1931-1935, 2008.
14. Pederson KB, Nesland JM, Fodstad O and Maelandsmo GM: Expression of S100A4, E-cadherin, α- and β-catenin in breast cancer biopsies. Br J Cancer 87: 1281-1286, 2002. (Pubitemid 36009134)
15. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schrami P, Leighton S, Tarhorst J, Mihatsch MJ, Sauter G and Kallioniemi OP: Tissue microarray for high-throughput molecular profiling of tumor specimens. Nat Med 4: 844-847, 1998. (Pubitemid 28331029)
16. Galfre G, Howe SC, Milstein C, Butcher GW and Howard JC: Antibodies to major histocompatibility antigens produced by hybridoma cell lines. Nature 266: 550-552, 1977.
17. Nishida, T and Yasuda H: PIAS1 and PIASxalpha function as SUMO-E3 ligases toward androgen receptor and repress androgen receptor-dependent transcription. J Biol Chem 277: 41311-41317, 2003. (Pubitemid 35257430)
18. Fukuoka J, Fujii T, Shih JH, Dracheva T, Meerzaman D, Player A, Hong K, Settnek S, Gupta A, Buetow K, Hewitt S, Travis WD and Jen J: Chromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in non-small cell lung cancer. Clinical Cancer Res 10: 4314-4324, 2004. (Pubitemid 38878869)
19. Fukuoka J, Dracheva T, Shi JH, Hewitt SM, Fujii T, Kishor A, Mann F, Shilo K, Franks TJ, Travis WD and Jen J: Desmoglein 3 as a prognostic factor in lung cancer. Hum Path 38: 276-283, 2007. (Pubitemid 46096551)
20. Donato R: S100: a multigenic family of calcium-modulated proteins of the EF-hhand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 33: 637-668, 2001.
21. Miyazaki N, Abe Y, Oida Y, Suemizu H, Nashi M, Yamazaki H, Iwasaki M, Inoue H, Ueyama Y and Nakamura M: Poor outcaome of patients with pulmonary adenocarcinoma showing decreased E-cadherin combined with increased S100A4 expression. Int J Oncol 28: 1369-1374, 2006.
22. Matsubara D, Niki T, Ishikawa S, Goto A, Ohara E, Yokomizo T, Heizmann CW, Aburatsni H, Moriyama H, Moriyama H, Nishimura Y, Funata N, and Fukuyama M: Differential expression of S100A2 and S100A4 in lung adenocarcinomas: Clinicopathological significance, relationship to p53 and identification of their taget genes. Cancer Sci 96: 844-857, 2005. (Pubitemid 43056122)
23. Kimura K, Endo Y, Yonemura Y, Heizmann CW, Schaefer BW, Watanabe Y and Sasaki T: Clinical significance of S100A4 and E-cadherin-related adhesion molecules in non-small cell lung cancer. Int J Oncol 16: 1125-1131, 2000.